Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Sirolimus (Primary) ; Everolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms DESSOLVE III
- 22 Mar 2016 According to a Micell Technologies media release, enrollment of 60 patients in the optical coherence tomography sub-study has been completed.
- 09 Dec 2015 Planned end date changed from 1 Oct 2018 to 1 Dec 2018, as reported by ClinicalTrials.gov.
- 09 Dec 2015 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016, as reported by ClinicalTrials.gov.